SSCVX
Price
$21.05
Change
-$0.08 (-0.38%)
Updated
Jul 13 closing price
Net Assets
420.82M
SSGSX
Price
$52.87
Change
-$0.12 (-0.23%)
Updated
Jul 13 closing price
Net Assets
4.55B
Interact to see
Advertisement

SSCVX vs SSGSX

SSCVX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
SSCVX vs. SSGSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSCVX is a StrongBuy and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.55B vs. SSCVX (421M). SSCVX pays higher dividends than SSGSX: SSCVX (0.65) vs SSGSX (0.51). SSCVX was incepted earlier than SSGSX: SSCVX (29 years) vs SSGSX (27 years). SSCVX (1.29) and SSGSX (1.23) have similar cost to investors . SSGSX is a more actively managed with annual turnover of: 50.00 vs. SSCVX (20.00). SSCVX (6%) and SSGSX (6%) have equivalent initial investment costs. SSCVX has a lower initial minimum investment than SSGSX: SSCVX (2000) vs SSGSX (2500). SSCVX annual gain was more profitable for investors over the last year : 21.36 vs. SSGSX (17.30). SSCVX return over 5 years is better than : 0.36 vs. SSGSX (-0.56).
SSCVXSSGSXSSCVX / SSGSX
Total Expense Ratio1.221.2399%
Annual Report Gross Expense Ratio1.291.23105%
Fund Existence29 years27 years-
Gain YTD26.67918.572144%
Front Load6%6%100%
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets421M4.55B9%
Annual Yield % from dividends0.650.51127%
Returns for 1 year21.3617.30123%
Returns for 3 years11.9911.95100%
Returns for 5 years0.36-0.56-64%
Returns for 10 years22.2141.0554%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGLD193.47-3.36
-1.71%
Royal Gold
ALT2.99-0.06
-1.97%
Altimmune
GEOS7.19-0.28
-3.75%
Geospace Technologies Corp
JEM0.50-0.04
-7.00%
707 Cayman Holdings Limited
RGC5.05-0.83
-14.12%
Regencell Bioscience Holdings Limited